9 Meters Biopharma, Inc.

NMTRQ

US6544052086

Investment Holding Companies

Market Closed - OTC Markets Other stock markets 07:43:22 28/05/2024 pm IST			5-day change	1st Jan Change
0.000001 ^USD	0.00%		0.00%	0.00%

25/03	North American Morning Briefing : Tech in Focus on -2-	DJ
2023	Bidding Procedure Approved for 9 Meters Biopharma, Inc.	CI

9 Meters Biopharma, Inc. Announces the Resignation of Nissim Darvish as Director

February 16, 2021 at 05:59 pm IST

On February 12, 2021, Dr. Nissim Darvish informed 9 Meters Biopharma, Inc. (the Company) that due to his move to a part time venture partner at Orbimed Advisors LLC, following his decision to start his own venture, he will resign from the Board of Directors of the Company, effective February 12, 2021.

Latest news about 9 Meters Biopharma, Inc.

North American Morning Briefing : Tech in Focus on -2-	25/03	DJ
Bidding Procedure Approved for 9 Meters Biopharma, Inc.	29/11	CI
Amendment to Motion for Asset Sale Filed by 9 Meters Biopharma, Inc.	27/11	CI
Motion for Asset Sale Filed by 9 Meters Biopharma, Inc.	07/11	CI
North American Morning Briefing : Stocks Look to -2-	06/11	DJ
Motion for Asset Sale Filed by 9 Meters Biopharma, Inc.	02/11	CI
North American Morning Briefing : Stock Futures -2-	22/23/22	DJ
North American Morning Briefing : Mood Seen Buoyed -2-	15/23/15	DJ
North American Morning Briefing : Apple's China Conflict, Rate Hike Fears Continue to Weigh	08/23/08	DJ
North American Morning Briefing : Jobs Report Eyed for Hiring Slowdown	01/23/01	DJ
North American Morning Briefing : Investors Await Powell's Jackson Hole Speech	25/23/25	DJ
North American Morning Briefing : China Trouble Hits Sentiment	18/23/18	DJ
North American Morning Briefing : Stock Futures -2-	11/23/11	DJ
Illumina cuts annual profit forecast as biotech funding woes linger	10/23/10	RE
Illumina cuts annual profit forecast	10/23/10	RE
9 Meters Biopharma, Inc.(OTCPK:NMTR.Q) dropped from NASDAQ Composite Index	25/23/25	CI
9 Meters Biopharma, Inc.(NasdaqCM:NMTR) dropped from S&P TMI Index	21/23/21	CI
Drug developer 9 Meters Biopharma files for bankruptcy protection	18/23/18	RE
9 Meters Biopharma, Inc. Filed for Bankruptcy	17/23/17	CI
9 Meters Biopharma Names Bethany Sensenig Interim Chief Executive; Shares Fall	30/23/30	MT
9 Meters Biopharma, Inc. Provides Clinical Update on Vurolenatide in Patients with Short Bowel Syndrome	30/23/30	CI
9 Meters Biopharma, Inc. Announces the Resignation of John Temperato as President	30/23/30	CI
9 Meters Biopharma, Inc. Announces the Resignation of John Temperato as Chief Executive Officer	30/23/30	CI
9 Meters Biopharma, Inc. Appoints Bethany Sensenig as Interim CEO	30/23/30	CI
Citigroup Adjusts 9 Meters Biopharma Price Target to $0.75 From $1.70, Maintains Neutral Rating	18/23/18	MT

Chart 9 Meters Biopharma, Inc.

Duration

Period

More charts

Company Profile

9 Meters Biopharma, Inc. has ceased operations. The Company has filed a voluntary petition for relief under provisions of Chapter 7 of Title 11 of the United States Code (the Bankruptcy Code) in the United States Bankruptcy Court for the Eastern District of North Carolina.

Sector

Investment Holding Companies

More about the company

	1st Jan change	Capi.
9 METERS BIOPHARMA, INC.	0.00%	14
TRUMP MEDIA & TECHNOLOGY GROUP CORP.	+185.31%	882.27Cr
CHURCHILL CAPITAL CORP VII	+2.29%	98Cr
APPLE ISPORTS GROUP, INC.	+41.91%	87Cr
PERELLA WEINBERG PARTNERS	+29.19%	84Cr
ARES ACQUISITION CORPORATION II	+2.01%	67Cr
E7 GROUP	+4.13%	63Cr
DA ZHONG TRADING GROUP HOLDING COMPANY	-.--%	60Cr
ADMIRAL ACQUISITION LIMITED	+10.56%	54Cr
CAPITOL INVESTMENT CORP. VII	-.--%	50Cr

Shell Companies